IAVI and its partners are advancing a diverse porfolio of select preventive HIV vaccine candidates.
IAVI details its organizational strategic vision for the period 2011-2015 made.
Engage with IAVI on your social media networks.
Since its founding in 1996, IAVI has evolved to become a full-scale AIDS vaccine research, advocacy and policy organization.
IAVI’s 2010 Annual Progress Report outlines key activities that support IAVI’s mission.
IAVI is led by a diverse group of individuals with expertise in a range of areas, including research and development, policy and advocacy.
IAVI is working with partners to ensure the development of a preventive HIV vaccine.
IAVI partners with organizations around the world to research and develop AIDS vaccines and to advocate for the field.
IAVI and its partners have established an international network of clinical
facilities and laboratories.